tiprankstipranks
Takeda Pharmaceutical Company (DE:TKDA)
FRANKFURT:TKDA
Germany Market
TKDA
Takeda Pharmaceutical Company
RESEARCH TOOLSreports

Takeda Pharmaceutical Company (TKDA) Income Statement

4 Followers

Takeda Pharmaceutical Company Income Statement

Last quarter (Q1 2026), Takeda Pharmaceutical Company's total revenue was ¥1.22T, an increase of 10.23% from the same quarter last year. In Q1, Takeda Pharmaceutical Company's net income was ¥113.20B. See Takeda Pharmaceutical Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 4.78T¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T
Gross Profit
¥ 2.44T¥ 3.00T¥ 2.83T¥ 2.78T¥ 2.46T
Operating Expenses
¥ 1.87T¥ 2.66T¥ 2.62T¥ 2.29T¥ 2.00T
Depreciation and Amortization
¥ 764.62B¥ 761.40B¥ 644.46B¥ 664.40B¥ 583.15B
EBITDA
¥ 1.42T¥ 1.21T¥ 1.14T¥ 1.28T¥ 1.18T
Operating Income
¥ 573.04B¥ 342.59B¥ 214.07B¥ 490.50B¥ 460.84B
Other Income/Expenses
¥ -297.16B¥ -167.50B¥ -161.28B¥ -115.42B¥ -158.27B
Pretax Income
¥ 275.88B¥ 175.08B¥ 52.79B¥ 375.09B¥ 302.57B
Net Income
¥ 203.33B¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B
Per Share Metrics
Basic EPS
¥ 63.91¥ 34.17¥ 46.05¥ 102.15¥ 73.57
Diluted EPS
¥ 63.91¥ 33.62¥ 45.58¥ 100.97¥ 72.94
Weighted Average Shares Outstanding
 3.15B 3.21B 3.13B 3.10B 3.13B
Weighted Average Shares Outstanding (Diluted)
 3.21B 3.21B 3.16B 3.14B 3.15B
Currency in JPY

Takeda Pharmaceutical Company Earnings and Revenue History